Summary
Updated Aug 31, 2026
Gaurav Aggarwal is Director of Unicycive Therapeutics, Inc. (UNCY). 3 SEC Form 4 filings on record going back to 2024, most recently on 25 August 2025.
Recent Transactions
2Every recent SEC Form 4 transaction Gaurav Aggarwal has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Gaurav Aggarwal go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Gaurav Aggarwal's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Eric Venker - $103.97M of ROIV open-market activity in the last 12 months
- Bruce Booth - $100.59M of KYMR open-market activity in the last 12 months
- Paul A. Mahon - $99.65M of UTHR open-market activity in the last 12 months
- ADAR1 Capital Management, LLC - $95.66M of KROS open-market activity in the last 12 months
- Steven Leonard Chapman - $93.37M of NTRA open-market activity in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M of KROS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gaurav Aggarwal?
Gaurav Aggarwal is a corporate insider, tracked as Director of Unicycive Therapeutics, Inc. (UNCY). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gaurav Aggarwal last file a Form 4?
The most recent primary Form 4 on record is dated 25 August 2025, one of 3 filings going back to 2024.
Where can I see all of Gaurav Aggarwal's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gaurav Aggarwal and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial